Study of LY3410738 Administered to Patients With Advanced Solid Tumors With IDH1 or IDH2 Mutations
Eli Lilly and Company
Eli Lilly and Company
St. Jude Children's Research Hospital
AbbVie
St. Jude Children's Research Hospital
Eastern Cooperative Oncology Group
Memorial Sloan Kettering Cancer Center
Children's Hospital of Philadelphia
Children's Oncology Group
Memorial Sloan Kettering Cancer Center
Alliance for Clinical Trials in Oncology
Alliance for Clinical Trials in Oncology
Dana-Farber Cancer Institute
NYU Langone Health
Children's Oncology Group
Children's Oncology Group
National Cancer Institute (NCI)
Children's Oncology Group
Universitätsklinikum Hamburg-Eppendorf
National Cancer Institute (NCI)
National Cancer Institute (NCI)
National Cancer Institute (NCI)
National Cancer Institute (NCI)
National Cancer Institute (NCI)
National Cancer Institute (NCI)
Children's Oncology Group
National Cancer Institute (NCI)
National Cancer Institute (NCI)
National Cancer Institute (NCI)
National Cancer Institute (NCI)
Barbara Ann Karmanos Cancer Institute
National Cancer Institute (NCI)
University of Southampton
St. Jude Children's Research Hospital
Mayo Clinic
Mayo Clinic